PRRC2A and cancer: Mutations in PRRC2A are associated with multiple cancers, including non-Hodgkin-Lymphoma (13), lung cancer (14), ER-positive breast cancer (15) and hepatocellular carcinoma, where they promote progression and immune infiltration (16).